Overview
PMP22-RAI1 contiguous gene duplication syndrome is a very rare genetic condition caused by a small extra copy (duplication) of a region on chromosome 17. This region contains two important genes: PMP22 and RAI1. Because both genes are duplicated at the same time, this condition combines features of two better-known disorders — Charcot-Marie-Tooth disease type 1A (caused by extra copies of PMP22) and Smith-Magenis syndrome (caused by changes in RAI1). The result is a condition that affects the nervous system, development, and behavior in overlapping ways. People with this syndrome typically experience problems with the nerves that control movement and sensation in the arms and legs (a peripheral neuropathy), along with intellectual disability, delayed speech and language, behavioral challenges, and distinctive physical features. Sleep disturbances are also commonly reported, which is a hallmark feature linked to the RAI1 gene. Some individuals may have heart defects, hearing loss, or vision problems. There is currently no cure for this syndrome. Care focuses on managing symptoms through physical therapy, speech therapy, occupational therapy, behavioral support, and treatment of specific medical problems as they arise. Because this condition is so rare, most of what is known comes from a small number of reported cases, and research is still in early stages.
Also known as:
Key symptoms:
Intellectual disability (ranging from mild to moderate)Delayed speech and language developmentMuscle weakness and reduced muscle tone (hypotonia)Nerve damage in the arms and legs causing weakness and numbness (peripheral neuropathy)Behavioral problems such as aggression, self-injury, or hyperactivitySleep disturbances, including difficulty falling or staying asleepDistinctive facial featuresShort statureHearing lossVision problemsHeart defects (in some individuals)Difficulty walking or problems with balance and coordination
Clinical phenotype terms (46)— hover any for plain English
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Infantile
Begins in infancy, roughly 1 month to 2 years old
Treatments
No FDA-approved treatments are currently listed for PMP22-RAI1 contiguous gene duplication syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for PMP22-RAI1 contiguous gene duplication syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for PMP22-RAI1 contiguous gene duplication syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to PMP22-RAI1 contiguous gene duplication syndrome.
Community
No community posts yet. Be the first to share your experience with PMP22-RAI1 contiguous gene duplication syndrome.
Start the conversation →Latest news about PMP22-RAI1 contiguous gene duplication syndrome
No recent news articles for PMP22-RAI1 contiguous gene duplication syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What specific duplication was found on my child's chromosome 17, and how large is it?,Which features of Charcot-Marie-Tooth disease and Smith-Magenis syndrome should we watch for most closely?,What therapies should we start right away, and how often should they happen?,Does my child need a heart evaluation, hearing test, or eye exam?,How will the nerve damage (neuropathy) progress over time, and what signs should prompt us to come back sooner?,Are there any patient registries or research studies we could join to help advance understanding of this condition?,What local or national support resources are available for families dealing with Smith-Magenis syndrome or Charcot-Marie-Tooth disease that might also help us?
Common questions about PMP22-RAI1 contiguous gene duplication syndrome
What is PMP22-RAI1 contiguous gene duplication syndrome?
PMP22-RAI1 contiguous gene duplication syndrome is a very rare genetic condition caused by a small extra copy (duplication) of a region on chromosome 17. This region contains two important genes: PMP22 and RAI1. Because both genes are duplicated at the same time, this condition combines features of two better-known disorders — Charcot-Marie-Tooth disease type 1A (caused by extra copies of PMP22) and Smith-Magenis syndrome (caused by changes in RAI1). The result is a condition that affects the nervous system, development, and behavior in overlapping ways. People with this syndrome typically ex
How is PMP22-RAI1 contiguous gene duplication syndrome inherited?
PMP22-RAI1 contiguous gene duplication syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does PMP22-RAI1 contiguous gene duplication syndrome typically begin?
Typical onset of PMP22-RAI1 contiguous gene duplication syndrome is infantile. Age of onset can vary across affected individuals.